Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)
Status:
Not yet recruiting
Trial end date:
2028-01-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, interventional, non-randomized study among patients with a relapsed or
refractory Wilms tumor. The study will aim to assess efficacy of metronomic chemotherapy, in
terms of disease control after two cycles of metronomic chemotherapy.